Jushi Holdings (JUSHF) Net Income towards Common Stockholders (QoQ) (2021 - 2026)
Jushi Holdings (JUSHF) Net Income towards Common Stockholders (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.07% |
| Mar 31, 2026 | -27.58% |
| Dec 31, 2025 | 34.33% |
| Sep 30, 2025 | -92.11% |
| Jun 30, 2025 | 27.53% |
| Mar 31, 2025 | -36.47% |
| Dec 31, 2024 | 22.15% |
| Sep 30, 2024 | -726.42% |
| Jun 30, 2024 | 89.44% |
| Mar 31, 2024 | -1.95% |
| Dec 31, 2023 | 12.70% |
| Sep 30, 2023 | -46.92% |
| Jun 30, 2023 | -12.83% |
| Mar 31, 2023 | 91.11% |
| Dec 31, 2022 | -155.85% |
| Sep 30, 2022 | -553.31% |
| Jun 30, 2022 | 161.07% |
| Mar 31, 2022 | -418.10% |
| Dec 31, 2021 | -84.35% |
| Sep 30, 2021 | 1,405.39% |